Twitxy Saved

Jeremy Schwartzentruber

@jschwart37

Scientist at Illumina using AI methods to interpret the non-coding genome and empower new genetic association discoveries.
Joined November 2013
234 Following 327 Followers 835 Posts

Latest posts 5

Pinned post

Jeremy Schwartzentruber @jschwart37
Let’s talk about rare variant association tests - we have a new method that helps you discover more with the same data! It’s called FlexRV to signal our approach: Flexibly modeling rare variant pathogenicity improves gene discovery for complex traits. biorxiv.org/content/10.110…
www.biorxiv.org Flexibly Modeling Rare Variant Pathogenicity Improves Gene Discovery for Complex Traits Rare variant burden tests can directly identify genes that influence complex traits, but their power is limited by our ability to separate functional from benign alleles. We introduce FlexRV, an...
1 replies 2 reposts 8 likes 2.2K views View on X
Jeremy Schwartzentruber @jschwart37
Eye-opening thread on what clinical trials for neurodegenerative diseases have really been focusing on for the past 20 years.
Eric Vallabh Minikel Verified account @cureffi Oct 24, 2022
To map the landscape of neurodegenerative disease clinical trials we analyzed 20 years of trial registrations.

The paper: nature.com/articles/s4159…

My blog post: cureffi.org/2022/10/24/pre…

Key findings in this thread 👇
View quoted post on X
Jeremy Schwartzentruber @jschwart37
What an incredible resource. Can't wait until it's publicly available.
Chris Whelan @chrisdwhelan Jun 19, 2022
Our pre-print describing the @uk_biobank Pharma Proteomics Project (UKB-PPP) is now online!

biorxiv.org/content/10.110…

We identify 10k+ genetic associations w/ protein concentrations; 85% are new.

The data should help drive discovery of new biomarkers, diagnostics & medicines.
View quoted post on X